Cladribine (Leustatin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cladribine (Leustatin), covering 2025-12-19 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Cladribine Venetoclax in Monocytic AML [Phase 2]